Pfizer's demolition plans in Groton stymie local officials

Now that Pfizer ($PFE) has wrapped up its big round of layoffs in Groton, CT, the company is bringing in the wrecking ball. And its plan to raze Building 118, Pfizer's sprawling 750,000-square-foot research facility on the campus, has made the locals hopping mad, from the governor on down. Report

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.